Javascript must be enabled to continue!
ASSOCIATION OF C-REACTIVE PROTEIN WITH HYPERLIPIDEMIA IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME IN KHYBER PAKHTUNKHWA
View through CrossRef
Background: It has been unknown whether there exist any relations of C-Reactive Protein (CRP) level with hyperlipidaemia in polycystic ovarian syndromes patients. To determine Association of CRP with Hyperlipidaemia in patients with polycystic ovarian syndrome. Method: This was a cross sectional descriptive study conducted among 50 each polycystic ovarian syndrome and normal women. After taking a written consent from participants predesigned questionnaire was filled including information regarding demography and medical history. A 3 to 5 ml blood was taken from patients and controls and transferred to laboratory for determination of CRP level and lipid profile. The test results were collected, compiled, entered and analyzed using SPSS Version 20 for determination of any kind of association of CRP with Hyperlipidaemia in patients with polycystic ovarian syndrome. Results: The mean age of study participants was 29.72±4.00 for cases and 29.04±3.99 for control. The cases and control were with the same age range, however there was a significant difference p=0.00 in BMI of the cases and control. There was no significant association observed between CRP and lipid profile parameters among polycystic ovarian syndrome patients. Conclusion: There exist no association between increasing CRP level and hyperlipidaemia in polycystic ovarian syndrome patients however CRP and lipid profile parameters showed high values among these patients.
Ayub Medical College, Abbottabad Pakistan
Title: ASSOCIATION OF C-REACTIVE PROTEIN WITH HYPERLIPIDEMIA IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME IN KHYBER PAKHTUNKHWA
Description:
Background: It has been unknown whether there exist any relations of C-Reactive Protein (CRP) level with hyperlipidaemia in polycystic ovarian syndromes patients.
To determine Association of CRP with Hyperlipidaemia in patients with polycystic ovarian syndrome.
Method: This was a cross sectional descriptive study conducted among 50 each polycystic ovarian syndrome and normal women.
After taking a written consent from participants predesigned questionnaire was filled including information regarding demography and medical history.
A 3 to 5 ml blood was taken from patients and controls and transferred to laboratory for determination of CRP level and lipid profile.
The test results were collected, compiled, entered and analyzed using SPSS Version 20 for determination of any kind of association of CRP with Hyperlipidaemia in patients with polycystic ovarian syndrome.
Results: The mean age of study participants was 29.
72±4.
00 for cases and 29.
04±3.
99 for control.
The cases and control were with the same age range, however there was a significant difference p=0.
00 in BMI of the cases and control.
There was no significant association observed between CRP and lipid profile parameters among polycystic ovarian syndrome patients.
Conclusion: There exist no association between increasing CRP level and hyperlipidaemia in polycystic ovarian syndrome patients however CRP and lipid profile parameters showed high values among these patients.
Related Results
Diagnostic value of shear wave velocity in polycystic ovarian syndrome
Diagnostic value of shear wave velocity in polycystic ovarian syndrome
Aim: In polycystic ovarian syndrome, the ovaries become stiffer due to chronic
anovulation. We aimed to compare tissue elasticity in terms of shear wave velocities
...
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
SUMMARY OBJECTIVE: Patients with polycystic ovary syndrome face an increased risk of developing metabolic syndrome. Identifying biomarkers that can detect metabolic syndrome in po...
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
P–688 Assessment of ovarian vascularity by three-dimensional vaginal power Doppler on day two of menstrual cycle to predict the number of mature eggs collected
Abstract
Study question
Could ovarian vascularity indices, measured by 3-dimensional (3D) vaginal power Doppler, predict the num...
Abstract DP-007: POLYCYSTIC OVARY SYNDROME AND OVARIAN CANCER RISK: A MENDELIAN RANDOMIZATION ANALYSIS
Abstract DP-007: POLYCYSTIC OVARY SYNDROME AND OVARIAN CANCER RISK: A MENDELIAN RANDOMIZATION ANALYSIS
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS), a complex endocrine disorder that has an estimated prevalence of 4-21% in reproductive aged women, is characte...
Effect of Knowledge Intervention on Polycystic Ovarian Syndrome among the Students of PJTSAU
Effect of Knowledge Intervention on Polycystic Ovarian Syndrome among the Students of PJTSAU
Polycystic ovarian syndrome (PCOS) is one of the most common reproductive endocrinological disorders with a broad spectrum of clinical manifestations affecting about 6-8% women of ...
Hyperlipidemia and Sexual Function in Premenopausal Women
Hyperlipidemia and Sexual Function in Premenopausal Women
ABSTRACT
Introduction
No reported studies exist assessing the relationship between sexual function and hyperlipidemia in ...

